|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.50 USD | -0.43% |
|
-7.62% | +13.44% |
| 09/07 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
| 08/07 | BofA Securities Adjusts Biogen Price Target to $217 From $203 | MT |
| Market Cap | 29.58B 25.88B 23.86B 22.08B 41.91B 2,824B 42.61B 286B 112B 1,387B 111B 109B 4,803B | P/E 2026 * |
30.5x | P/E 2027 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.09B 30.7B 28.31B 26.19B 49.71B 3,349B 50.54B 339B 133B 1,645B 132B 129B 5,697B | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.19x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | -0.43% | ||
| 1 week | -7.62% | ||
| Current month | -7.60% | ||
| 1 month | +0.28% | ||
| 3 months | +12.73% | ||
| 6 months | +6.41% | ||
| Current year | +13.44% |
| 1 week | 196 | 215.95 | |
| 1 month | 193.2 | 219.72 | |
| Current year | 160.36 | 219.72 | |
| 1 year | 121.05 | 219.72 | |
| 3 years | 110.04 | 282.74 | |
| 5 years | 110.04 | 358.77 | |
| 10 years | 110.04 | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.43% | -7.62% | +50.09% | -29.10% | 29.58B | ||
| +0.43% | +1.80% | +20.53% | -5.31% | 67.44B | ||
| +0.52% | -5.52% | +46.80% | +218.71% | 53.98B | ||
| -2.79% | +32.50% | +32.50% | +32.50% | 41.77B | ||
| +0.99% | +6.05% | -48.96% | -52.97% | 41.15B | ||
| +2.72% | -4.91% | +131.31% | -38.38% | 29.28B | ||
| +0.81% | +1.14% | +71.99% | +90.97% | 23.43B | ||
| +0.17% | +8.48% | +4.86% | +185.45% | 19.11B | ||
| +1.14% | -0.17% | +68.83% | +134.48% | 16.82B | ||
| +17.24% | +18.93% | +99.65% | +428.80% | 15.36B | ||
| Average | +2.08% | +1.68% | +47.76% | +96.52% | 33.79B | |
| Weighted average by Cap. | +1.05% | +1.23% | +38.61% | +68.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.04B 8.78B 8.1B 7.49B 14.22B 958B 14.46B 96.96B 38.01B 470B 37.68B 36.86B 1,630B | 10.35B 9.05B 8.35B 7.72B 14.66B 988B 14.9B 99.95B 39.18B 485B 38.84B 38B 1,680B |
| Net income | 1.51B 1.32B 1.22B 1.13B 2.14B 144B 2.18B 14.61B 5.73B 70.9B 5.68B 5.56B 246B | 1.95B 1.7B 1.57B 1.45B 2.76B 186B 2.81B 18.82B 7.38B 91.29B 7.31B 7.15B 316B |
| Net Debt | 5.51B 4.82B 4.44B 4.11B 7.8B 526B 7.93B 53.22B 20.86B 258B 20.68B 20.23B 894B | 3.38B 2.96B 2.73B 2.53B 4.8B 323B 4.88B 32.7B 12.82B 159B 12.71B 12.43B 550B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | USD 199.65 | -0.35% | 648,113 |
| 08/07/26 | USD 200.36 | -2.60% | 1,947,888 |
| 07/07/26 | USD 205.70 | -1.32% | 1,156,880 |
| 06/07/26 | USD 208.46 | -3.54% | 1,218,492 |
| 02/07/26 | USD 216.12 | +3.04% | 1,155,165 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions

















